Illumina shares details of semiconductor-based sequencing device

Illumina CEO Jay Flatley

Illumina ($ILMN) CEO Jay Flatley has shared details of Project Firefly, the genomic leader's move into semiconductor-based sequencing. At a presentation at Advances in Genome Biology and Technology attended by GenomeWeb, Flatley said the sequencing device is a CMOS sensor with nanowells. In early internal tests, the device achieved 99% raw read accuracy, putting it in the same league as the HiSeq X system. Article (reg. req.)

Suggested Articles

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.